These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18688653)

  • 41. A Phase II, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major.
    Yesilipek MA; Karasu G; Kaya Z; Kuskonmaz BB; Uygun V; Dag I; Ozudogru O; Ertem M
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):613-618. PubMed ID: 29155313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
    Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
    Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparable Outcomes of Allogeneic Peripheral Blood versus Bone Marrow Hematopoietic Stem Cell Transplantation in Major Thalassemia: A Multivariate Long-Term Cohort Analysis.
    Ghavamzadeh A; Kasaeian A; Rostami T; Kiumarsi A
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):307-312. PubMed ID: 30266673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.
    Bernardo ME; Piras E; Vacca A; Giorgiani G; Zecca M; Bertaina A; Pagliara D; Contoli B; Pinto RM; Caocci G; Mastronuzzi A; La Nasa G; Locatelli F
    Blood; 2012 Jul; 120(2):473-6. PubMed ID: 22645178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hematopoietic stem cell transplantation for children with thalassemia major in China.
    Fang JP; Xu LH
    Pediatr Blood Cancer; 2010 Dec; 55(6):1062-5. PubMed ID: 20979169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune recovery after in vivo T-cell depletion myeloablative conditioning hematopoietic stem cell transplantation in severe beta-thalassemia children.
    Qin F; Shi L; Li Q; Zhang Z; Liu L; Li J; Yang G; Lai YR
    Eur J Haematol; 2019 Oct; 103(4):342-350. PubMed ID: 31276236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative evaluation of renal findings in Beta-thalassemia major and intermedia.
    Ali D; Mehran K; Moghaddam AG
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):206-9. PubMed ID: 18310868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cystatin C, Beta2 Microglobulin, N-Acetyl-beta-D-glucosaminidase, Retinol-Binding Protein, and Endothelin 1 Levels in the Evaluation of Sickle Cell Disease Nephropathy.
    Unal S; Kotan C; Delibas A; Oztas Y
    Pediatr Hematol Oncol; 2015 May; 32(4):250-7. PubMed ID: 23987825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group.
    Yesilipek MA; Ertem M; Cetin M; Öniz H; Kansoy S; Tanyeli A; Anak S; Kurekci E; Hazar V
    Pediatr Transplant; 2012 Dec; 16(8):846-51. PubMed ID: 22931438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T2(∗) MRI changes in the heart and liver of ex-thalassemic patients after hematopoietic stem cell transplantation.
    Hamidieh AA; Tayebi S; Moeininia F; Shamshiri AR; Behfar M; Alimoghaddam K; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):103-8. PubMed ID: 24998835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Posterior Reversible Encephalopathy Syndrome in Pediatric Hematopoietic Stem Cell Transplantation with Beta Major Thalassemia: The Association between the PRES Occurrence and Class of Beta Major Thalassemia.
    Jafari L; Behfar M; Tabatabaie S; Karamlou Y; Kashani H; Radmard AR; Mohseni R; Naji P; Ghanbari F; Ashkevari P; Fakhr H; Mohammadi S; Hamidieh AA
    Clin Transplant; 2024 Jan; 38(1):e15164. PubMed ID: 37847603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective study of tubular dysfunction in pediatric patients with Beta thalassemia major receiving deferasirox.
    Naderi M; Sadeghi-Bojd S; Valeshabad AK; Jahantigh A; Alizadeh S; Dorgalaleh A; Tabibian S; Bamedi T
    Pediatr Hematol Oncol; 2013 Nov; 30(8):748-54. PubMed ID: 24134694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen.
    Sun L; Wang N; Chen Y; Tang L; Xing C; Lu N; Shi Y; Ma Y; Lin F; Yu K; Feng J
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1592-1596. PubMed ID: 30951841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early markers of renal dysfunction in patients with beta-thalassemia major.
    Mohkam M; Shamsian BS; Gharib A; Nariman S; Arzanian MT
    Pediatr Nephrol; 2008 Jun; 23(6):971-6. PubMed ID: 18288499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
    Atay D; Erbey F; Akcay A; Ozturk G
    Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
    Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal tubular proteinuria and microalbuminuria in diabetic patients.
    Gibb DM; Tomlinson PA; Dalton NR; Turner C; Shah V; Barratt TM
    Arch Dis Child; 1989 Jan; 64(1):129-34. PubMed ID: 2923463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.
    Rostami T; Monzavi SM; Poustchi H; Khoshdel AR; Behfar M; Hamidieh AA
    Int J Hematol; 2021 Jan; 113(1):145-157. PubMed ID: 33033952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase (NAG) as early markers of renal tubular dysfunction in sick neonates.
    Chen JY; Lee YL; Liu CB
    J Formos Med Assoc; 1991 Feb; 90(2):132-7. PubMed ID: 1678405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.
    Kersting S; Verdonck LF
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1312-6. PubMed ID: 18940687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.